NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

狂犬病(恐水症)診斷的全球市場

Rabies Diagnostics

出版商 Global Industry Analysts, Inc. 商品編碼 993896
出版日期 內容資訊 英文 280 Pages
商品交期: 最快1-2個工作天內
價格
狂犬病(恐水症)診斷的全球市場 Rabies Diagnostics
出版日期: 2021年04月01日內容資訊: 英文 280 Pages
簡介

全球狂犬病(恐水症)診斷的市場規模,預計在分析期間(2020年∼2027年)將以4%的年複合成長率增長,從2020年的16億美元,到2027年達到21億美元。

本報告所分析的市場區隔之一的螢光抗體試驗(FAT)部門,在分析期間中預計將以3.8%的年複合成長率增長,達到6億9,390萬美元。

本報告提供全球狂犬病(恐水症)診斷市場的相關調查,提供市場佔有率,Covid-19的影響,趨勢和成長要素,各地區的市場分析,競爭情形,主要企業的簡介等資訊。

調查對象企業範例

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

目錄

I. 調查手法

II. 摘要整理

  • 市場概要
    • 影響者市場洞察
    • 全球市場的軌跡
    • Covid-19的影響與即將到來的全球景氣衰退
    • 競爭的市場佔有率
    • 競爭的市場佔有率方案
    • 競爭的市場佔有率:各市場區隔
  • 主要企業
  • 趨勢與推動要素
  • 全球市場預測

III. 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美國家
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東
  • 非洲

IV. 競爭

  • 企業簡介:34公司

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP22670

Abstract:

Global Rabies Diagnostics Market to Reach $2.1 Billion by 2027

Amid the COVID-19 crisis, the global market for Rabies Diagnostics estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.1 Billion by 2027, growing at a CAGR of 4% over the analysis period 2020-2027. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is projected to record a 3.8% CAGR and reach US$693.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immunohistochemical Tests segment is readjusted to a revised 4.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $432 Million, While China is Forecast to Grow at 6.4% CAGR

The Rabies Diagnostics market in the U.S. is estimated at US$432 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$424.3 Million by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.4% and 3.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Amplification Methods Segment to Record 4.5% CAGR

In the global Amplification Methods segment, USA, Canada, Japan, China and Europe will drive the 4.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$277.1 Million in the year 2020 will reach a projected size of US$371.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$277.7 Million by the year 2027, while Latin America will expand at a 4.9% CAGR through the analysis period.

Select Competitors (Total 34 Featured) -

  • Abbexa Ltd.
  • Aviva Systems Biology Corporation
  • BioNote, Inc.
  • Bio-Rad Laboratories, Inc.
  • Creative Diagnostics
  • Demeditec Diagnostics GmbH
  • Express Biotech International Inc.
  • Merck KGaA
  • MyBioSource.com
  • Norgen Biotek Corp.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Rabies Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Fluorescent Antibody Tests (FAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Fluorescent Antibody Tests (FAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Immunohistochemical Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Immunohistochemical Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Amplification Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Amplification Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Histologic Examinations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Histologic Examinations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Serology Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Serology Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for ELISA / Immunohistochemistry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for ELISA / Immunohistochemistry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Chromatography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Chromatography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 26: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: World 15-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 31: USA Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: USA Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: USA 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 34: USA Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: USA Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: USA 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 37: Canada Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Canada Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Canada 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 40: Canada Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Canada Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Canada 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 43: Japan Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Japan Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: Japan 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 46: Japan Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Japan Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: Japan 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 49: China Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: China Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: China 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 52: China Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: China Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: China 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 55: Europe Current & Future Analysis for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Rabies Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 58: Europe Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: Europe 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 61: Europe Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: Europe 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 64: France Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: France Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: France 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 67: France Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: France Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: France 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 70: Germany Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Germany Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Germany 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 73: Germany Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Germany Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Germany 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 76: Italy Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: Italy Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: Italy 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 79: Italy Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: Italy Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: Italy 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 82: UK Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: UK Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: UK 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 85: UK Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: UK Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: UK 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 88: Spain Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Spain Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Spain 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 91: Spain Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Spain Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Spain 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 94: Russia Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Russia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Russia 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 97: Russia Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Russia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Russia 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 101: Rest of Europe Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 102: Rest of Europe 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 103: Rest of Europe Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 104: Rest of Europe Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 105: Rest of Europe 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 106: Asia-Pacific Current & Future Analysis for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 107: Asia-Pacific Historic Review for Rabies Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 108: Asia-Pacific 15-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 109: Asia-Pacific Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 110: Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 111: Asia-Pacific 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 112: Asia-Pacific Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 113: Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 114: Asia-Pacific 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 115: Australia Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 116: Australia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 117: Australia 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 118: Australia Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 119: Australia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 120: Australia 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 121: India Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 122: India Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 123: India 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 124: India Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 125: India Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 126: India 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 127: South Korea Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 128: South Korea Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 129: South Korea 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 130: South Korea Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 131: South Korea Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 132: South Korea 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 133: Rest of Asia-Pacific Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 134: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 135: Rest of Asia-Pacific 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 136: Rest of Asia-Pacific Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 137: Rest of Asia-Pacific Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 138: Rest of Asia-Pacific 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 139: Latin America Current & Future Analysis for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 140: Latin America Historic Review for Rabies Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 141: Latin America 15-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 142: Latin America Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 143: Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 144: Latin America 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 145: Latin America Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 146: Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 147: Latin America 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 148: Argentina Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 149: Argentina Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 150: Argentina 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 151: Argentina Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 152: Argentina Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 153: Argentina 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 154: Brazil Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 155: Brazil Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 156: Brazil 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 157: Brazil Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 158: Brazil Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 159: Brazil 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 160: Mexico Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 161: Mexico Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 162: Mexico 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 163: Mexico Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 164: Mexico Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 165: Mexico 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 166: Rest of Latin America Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 167: Rest of Latin America Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 168: Rest of Latin America 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 169: Rest of Latin America Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 170: Rest of Latin America Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 171: Rest of Latin America 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 172: Middle East Current & Future Analysis for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 173: Middle East Historic Review for Rabies Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 174: Middle East 15-Year Perspective for Rabies Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 175: Middle East Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 176: Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 177: Middle East 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 178: Middle East Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 179: Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 180: Middle East 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 181: Iran Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 182: Iran Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 183: Iran 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 184: Iran Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 185: Iran Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 186: Iran 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 187: Israel Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 188: Israel Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 189: Israel 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 190: Israel Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 191: Israel Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 192: Israel 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 193: Saudi Arabia Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 194: Saudi Arabia Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 195: Saudi Arabia 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 196: Saudi Arabia Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 197: Saudi Arabia Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 198: Saudi Arabia 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 199: UAE Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 200: UAE Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 201: UAE 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 202: UAE Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 203: UAE Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 204: UAE 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 205: Rest of Middle East Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 206: Rest of Middle East Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 207: Rest of Middle East 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 208: Rest of Middle East Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 209: Rest of Middle East Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 210: Rest of Middle East 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 211: Africa Current & Future Analysis for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 212: Africa Historic Review for Rabies Diagnostics by Method - Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 213: Africa 15-Year Perspective for Rabies Diagnostics by Method - Percentage Breakdown of Value Sales for Fluorescent Antibody Tests (FAT), Immunohistochemical Tests, Amplification Methods, Histologic Examinations and Serology Tests for the Years 2012, 2020 & 2027
    • TABLE 214: Africa Current & Future Analysis for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 215: Africa Historic Review for Rabies Diagnostics by Technology - ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 216: Africa 15-Year Perspective for Rabies Diagnostics by Technology - Percentage Breakdown of Value Sales for ELISA / Immunohistochemistry, Chromatography, PCR and Other Technologies for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 34